MacroShed Daily: Iran Sanctions, $40 Trillion Debt, and an mRNA Cancer Trial

U.S. expands economic pressure on Iran

Washington announced a sanctions campaign intended to compel Iran to end its nuclear program and fully reopen the Strait of Hormuz. The move comes nearly six months into the U.S.-Israeli war with Iran, with energy shipping disrupted and weapons inventories constrained. The confrontation places a major oil chokepoint, nuclear risk, and wider regional escalation in the same crisis. The package’s operational details remain limited, and Iran has previously endured extensive sanctions.

U.S. federal debt exceeds $40 trillion

U.S. federal debt crossed $40 trillion for the first time as long-dated Treasury yields approached two-decade highs. Treasury plans substantially larger repurchases of long-dated government debt. Higher benchmark sovereign yields can raise borrowing costs for governments, housing, infrastructure, and private investment. No acute U.S. funding crisis has occurred, and the gross-debt figure alone does not establish insolvency.

Personalized mRNA melanoma therapy reports Phase 3 success

Moderna and Merck said intismeran, an individualized neoantigen therapy used with Keytruda, significantly reduced melanoma recurrence or spread in a late-stage trial. Nature described it as the first Phase 3 success for an mRNA-based cancer treatment. The result could support development of programmable, patient-specific cancer vaccines for other solid tumors. Full numerical results, safety details, and regulatory review remain outstanding, and the reported result concerns melanoma.

Panama Canal tightens shipping limits

The Panama Canal will reduce daily transits and allowable vessel draft after rainfall from May through August ran about 34% below its historical average. Further restrictions remain possible. Capacity constraints at the canal could increase freight costs and add pressure to supply chains already exposed to disruption around Hormuz and the Black Sea. The initial reductions are moderate and could be reversed if rainfall improves.

Google aligns with Marvell on custom AI silicon

Google selected Marvell to develop chips connected to its TPU ecosystem and received warrants to buy nearly 59 million Marvell shares, valued at about $12.2 billion at the exercise price. The arrangement strengthens Google’s custom-compute strategy and could make Marvell a larger supplier in the TPU hardware stack. The warrant value does not represent immediate spending, and future revenue depends on deployment milestones.

Ukraine’s internal political challenge loses momentum

Ousted defense minister Mykhailo Fedorov called for elections and described a systemic governance crisis, creating the largest internal challenge to President Volodymyr Zelenskyy since Russia’s full-scale invasion. The campaign subsequently failed to retain protest support. Political cohesion affects Ukraine’s mobilization, foreign support, military administration, and negotiating position. The immediate challenge appears to have reduced its near-term capacity to alter the government.

Cerebras unveils a new wafer-scale AI system

Cerebras introduced CS-4, a system built from three wafer-scale processors for hyperscale inference. The company says it can deliver up to 30 times the inference speed of GPU systems and interactive performance on models exceeding ten trillion parameters. If independently validated and deployed economically, the architecture could broaden competition beyond conventional GPU clusters. Its performance figures are company claims, while adoption and operating costs at scale remain uncertain.